Business · 02/02/2022Updated: 10/17/2026 · 1 min read
Hikma Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 29 New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing the approval of 29 new drug applications from multiple applicants, including Hikma Pharmaceuticals USA, Inc., after the applicants notified the Agency that the drug products are no longer on the market.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →